Search
for
Sort by
Research 61–90 of 68
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- 1,314
- New Drugs for Alopecias
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28‐Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
- Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata
- A Case of Unexpected Successful Treatment of Alopecia Areata With Tralokinumab in a Patient With Atopic Dermatitis
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Biologics in the management of childhood atopic dermatitis
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Treatment of Lichen Planopilaris With Abrocitinib
- New Modalities in the Treatment of Refractory Alopecia Areata
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Systemic treatments for alopecia areata: A systematic review
- A novel therapeutic paradigm for patients with extensive alopecia areata
- New drugs under investigation for the treatment of alopecias
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Pharmacological Treatment of Alopecia
- Clinical Trials and Hair Loss
- Novel drugs of United States Food and Drug Administration approved in 2024